Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis
Abstract
Background/aims Estrogen receptors (ER) in cholangiocytes of primary biliary cirrhosis (PBC) patients and their relationship with cell proliferation and death were evaluated. Methods Liver biopsies from PBC patients with different histological stages were investigated by immunohistochemistry for ER-alpha and -beta, cytokeratin-19, proliferating cellular nuclear antigen (PCNA), Fas and terminal deoxynucleotide transferase end labelling (TUNEL). Normal livers and livers from primary sclerosing cholangitis and alcoholic cirrhosis were investigated as controls. Results ER-alpha and -beta were observed in cholangiocytes of PBC patients but not in normal liver. In PBC, positivity for ER-beta was high (50-65 %) in all histological stages while, positivity for ER-alpha increased from 1% in stage I to 12 % in stage III (positivity correlated and co-localized in the same cell with PCNA). In stage IV of PBC, cholangiocytes were negative for ER-alpha in association with a lower PCNA positivity and with maximal degree of ductopenia. ER-alpha positivity in cholangiocytes of PBC patients was markedly lower than primary sclerosing cholangitis and alcoholic cirrhosis. Conclusions ER are expressed in PBC and other pathologies associated with cholangiocyte proliferation but not in normal subjects. The low expression of ER-alpha in PBC and their disappearance in the advanced histological stages suggests that an estrogenic deficiency could favour the evolution of this disease toward ductopenia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In patients with primary biliary cholangitis, oestrogen receptors are also present in cholangiocytes.
“In patients with primary biliary cholangitis, oestrogen receptors are also present in cholangiocytes.22”
From Primary biliary cholangitis. (2024) · cites this paper as [22]
Cited by
Sorted by citations
Gershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621 · see citing works
Carbone, M., Mells, G. F., Pells, G., Dawwas, M. F., Newton, J. L., Heneghan, M. A., Neuberger, J. M., Day, D. B., Ducker, S. J., Sandford, R. N., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.005 · Cited by 386 · see citing works
Tanaka, A., Ma, X., Takahashi, A., & Vierling, J. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01303-5 · Cited by 177 · see citing works
Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30163-8 · Cited by 155 · see citing works
Self-citationMarzioni, M., Alpini, G., Saccomanno, S., Candelaresi, C., Venter, J., Rychlicki, C., Fava, G., Francis, H., Trozzi, L., Glaser, S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.007 · Cited by 96 · see citing works
Questionnaire based assessment of risk factors for primary biliary cirrhosis
Lammert, C., Nguyen, D. L., Juran, B. D., Schlicht, E., Larson, J. J., Atkinson, E. J., & Lazaridis, K. N. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.01.028 · Cited by 40 · see citing works
The immunobiology of female predominance in primary biliary cholangitis
Gerussi, A., Cristoferi, L., Carbone, M., Asselta, R., & Invernizzi, P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.015 · Cited by 41 · see citing works
Self-citation
- Authors
- Alvaro, D., Invernizzi, P., Onori, P., Franchitto, A., De Santis, A., Crosignani, A., Sferra, R., Ginanni-Corradini, S., Grazia Mancino, M., Maggioni, M., Attili, A. F., Podda, M., & Gaudio, E.
- Affiliations
- Sapienza University of Rome (IT)
- University of Milan (IT)
- University of L'Aquila (IT)
- Corresponding author
- Alvaro, Domenico
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 41
- Issue
- 6
- Pages
- 905-912
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2091482013
- Cited by
- 134
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 19 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 10
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- estrogen receptor, estrogen receptor alpha, estrogen receptor beta, cholangiocytes, primary biliary cirrhosis, disease progression, ductopenia, cell proliferation, apoptosis, primary sclerosing cholangitis, alcoholic cirrhosis, estrogen deficiency
- MeSH terms
- Bile Ducts, Intrahepatic, Cell Division, Humans, Immunohistochemistry, Liver, Liver Cirrhosis, Alcoholic, Liver Cirrhosis, Biliary, Cholangitis, Sclerosing, Biomarkers, Case-Control Studies, Apoptosis, Disease Progression, Proliferating Cell Nuclear Antigen, Estrogen Receptor alpha, Estrogen Receptor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review